{"id":"W2596486877","doi":"10.1200/jco.2004.22.90140.630","title":"A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic breast cancer; Anthracycline; Trastuzumab; Ejection fraction; Cardiotoxicity; Doxorubicin; Internal medicine; Breast cancer; Cancer; Heart failure; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047805,0.00166029,0.001645381,0.0004178544,0.0007950838,0.0008984139,0.001221931,0.001259041,0.003452124],"category_scores_gemma":[0.0007602473,0.0006767598,0.000811204,0.0005744483,0.001060514,0.0004856754,0.0005195391,0.002290475,0.0007255068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003919715,"about_ca_system_score_gemma":0.006109642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02929591,"about_ca_topic_score_gemma":0.06172748,"domain_scores_codex":[0.9994648,0.000195997,0.0000247669,0.00009358376,0.0000771315,0.0001437292],"domain_scores_gemma":[0.9991059,0.00006484251,0.00009780289,0.00005000321,0.00005407213,0.0006274287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8085489,0.08396479,0.008895046,0.0005811716,0.0007645297,0.0003614733,0.0004770829,0.001857934,0.03122055,0.0001370214,0.00422033,0.05897114],"study_design_scores_gemma":[0.6747915,0.2942178,0.02490193,0.00002935035,0.0003159131,0.0002857068,0.00006495684,0.000838389,0.002147159,0.00007240718,0.002305693,0.00002915232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925575,0.0008343243,0.0002757832,0.000281428,0.00005884668,0.004096824,0.0007070638,0.00005044476,0.001137801],"genre_scores_gemma":[0.9886386,0.001033269,0.001694587,0.0006688592,0.0001317187,0.003313865,0.00229551,0.00001930324,0.002204127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02929591,"threshold_uncertainty_score":0.05825078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1422473115020502,"score_gpt":0.5265052184546788,"score_spread":0.3842579069526286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}